HOME >> BIOLOGY >> NEWS
Stem-cell research and reproductive cloning laws should be separate

The author of a Public Policy article in this week's issue of THE LANCET discusses recent failures of international organisations to establish clear policies with regard to stem-cell research and reproductive cloning. This will have implications for research scientists who will not be clear about the type of research programmes that could be publicly funded or that are legally permissible in the near future.

Carol A Tauer (Center for Bioethics, University of Minnesota, USA) outlines how late last year two international bodies were unable to resolve disagreements that involved bioethical issues. First, the United Nations General Assembly failed to pass a treaty on reproductive cloning because of insistence by some countries that the treaty include a ban on cloning for research. She argues that in view of the importance of enacting prohibition of reproductive cloning, the two issues should be separated and each argued on its own merits. Second, Dr Tauer discusses how the European Union (EU) failed to agree on conditions for funding stem-cell research because of the diversity of views and policies of the countries of the EU. Because a stalemate was reached, funding decisions in the next programme cycle will be made on an ad hoc basis.

Dr Tauer comments: "A country or group of countries can legitimately not fund certain controversial types of scientific or biomedical research. But a decision is preferable to a stalemate. Scientists who do not know what types of research proposals can be considered for funding are likely to shy away from a particular area of investigation. In this respect, the US rules, while restrictive, might have some advantages over the EU's lack of agreement on rules. If clear rules exist about what can and cannot be publicly funded then scientists can plan and seek private funding if necessary. The EU needs to break its stalemate and agree on funding policies, if not within the Sixth Framework Programme then at least by the time o
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
8-Jul-2004


Page: 1 2

Related biology news :

1. Stem-cell therapy could have benefits and risks for heart-attack PTs
2. Stem-cell defect underlies common genetic disorder
3. Leader in cancer treatment and prevention research honored
4. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
5. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
6. Belgian researchers explore revolutionary approach to angiogenesis
7. Award winning researchers reveal potential new role for Glivec
8. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
9. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
10. Gene chips research in cotton could lead to superior variety
11. Groundbreaking research could ignite new solutions to heat transfer in nano-devices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... ... October 09, 2018 , ... ... identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies, announced ... national nonprofit disease foundations to discuss their investment philosophies, explain their fund ...
(Date:10/11/2018)... ... , ... ODSC Europe 2018 - one of Open Data Science Conference ... from September 19-22. , As Europe’s largest applied data science conference, ODSC Europe ... days. Attendees were given key insights and hands-on training in deep learning, ...
(Date:10/5/2018)... ... October 05, 2018 , ... The Amino Acid Technologies ... 10% price increase across all markets in January 2019. , The global ... of protein — for the parenteral nutrition, biopharmaceutical, infant/medical food, supplement and nutrition ...
Breaking Biology News(10 mins):
(Date:10/3/2018)... ... October 03, 2018 , ... Milwaukee Area Technical College ... Wednesday, Oct. 17, from 3-7 p.m. in Room T129 in the T Building, 101 ... new CNC Swiss Lab. A ribbon cutting and formal program will be held at ...
(Date:9/29/2018)... (PRWEB) , ... September 29, 2018 , ... ... product enabling mid-level and early-stage companies to access the power of influence analytics ... our solutions available to a broader market that didn’t necessarily have access to ...
(Date:9/27/2018)... ... , ... Medable was named DPharm Idol at this year’s ... digitome, a digital representation of human health and disease, by removing the separation ... sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that their approach ...
(Date:9/22/2018)... HAYWARD, Calif. and WESTMINSTER, Colo. (PRWEB) , ... ... ... Predicine and Flagship Biosciences are excited to announce a strategic venture. ... intelligence-enabled cTA® digital pathology platform provides complimentary and comprehensive biomarker profiling to ...
Breaking Biology Technology:
Cached News: